In reference samples, out-of-specification (OOS) results were found for atomoxetine content, and for batch 1304011 also for capsule mass uniformity, which may affect dosing. Potential effects: reduced treatment efficacy or adverse reactions due to incorrect dose.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use products from the listed batches; check the batch number of any packs you have and, if applicable, consult a doctor or pharmacist and return the product to the pharmacy.
The Chief Pharmaceutical Inspector suspended distribution throughout the country of the specified batches of Konaten and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related